Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;8(17):1096.
doi: 10.21037/atm-20-4355.

In vivo retinal imaging in translational regenerative research

Affiliations
Review

In vivo retinal imaging in translational regenerative research

Ifat Sher et al. Ann Transl Med. 2020 Sep.

Abstract

Regenerative translational studies must include a longitudinal assessment of the changes in retinal structure and function that occur as part of the natural history of the disease and those that result from the studied intervention. Traditionally, retinal structural changes have been evaluated by histological analysis which necessitates sacrificing the animals. In this review, we describe key imaging approaches such as fundus imaging, optical coherence tomography (OCT), OCT-angiography, adaptive optics (AO), and confocal scanning laser ophthalmoscopy (cSLO) that enable noninvasive, non-contact, and fast in vivo imaging of the posterior segment. These imaging technologies substantially reduce the number of animals needed and enable progression analysis and longitudinal follow-up in individual animals for accurate assessment of disease natural history, effects of interventions and acute changes. We also describe the benefits and limitations of each technology, as well as outline possible future directions that can be taken in translational retinal imaging studies.

Keywords: Retinal imaging; adaptive optics (AO); fundus imaging; optical coherence tomography (OCT).

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm-20-4355). The series “Novel Tools and Therapies for Ocular Regeneration” was commissioned by the editorial office without any funding or sponsorship. The authors have no other conflicts of interest to declare.

Figures

Figure 1
Figure 1
NIR-FAF (A,B,C) and SW-FAF (D,F) imaging of WT, non-dystrophic Long Evens (LE) rats (A,D) and dystrophic RCS rats at age postnatal day [p]28 (B,E) and p84 (C,F). At p28, the SW-FAF signal is weak. At p84, the SW-FAF image of RCS rats is characterized by a strong hyperautofluorescence and the appearance of discrete hypofluorescent lesions surrounded by hyperfluorescent flecks around the optic nerve head. No hypofluorescent lesions are found in LE rats. These hypofluorescent lesions are barely detectable by NIR-FAF (C, red arrow points to a dateable lesion). The figure is modified from our previous publication (55).
Figure 2
Figure 2
Multimodal imaging for longitudinal follow-up of retinal degeneration in RCS rats. SW-FAF imaging (A,D,G) and corresponding SD-OCT scans (B,E,H) of the central retina area in a representative WT, non-dystrophic Long Evans (LE) rat and a single-representative RCS rat at different ages (p28, p84). (C,F,I) A zoomed-in view of the SD-OCT shown in (B,E,H), respectively. The vertical lines in panels (C,F,I) highlight the ONL (red), total retina (yellow) and debris zone [DZ, in blue, panel (F)]. The hypofluorescent lesion detected in the SW-FAF scan [highlighted by red lines, (G)] corresponded to focal loss of the DZ (H,I). The green vertical lines in panels (A,D,G) indicate the position from which the SD-OCT scans on the right were taken.

Similar articles

Cited by

References

    1. FDA. FDA approves novel gene therapy to treat patients with a rare form of inherited vision loss. Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-novel-g...
    1. Machida S, Kondo M, Jamison JA, et al. P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci 2000;41:3200-9. - PubMed
    1. Tzameret A, Sher I, Belkin M, et al. Transplantation of human bone marrow mesenchymal stem cells as a thin subretinal layer ameliorates retinal degeneration in a rat model of retinal dystrophy. Exp Eye Res 2014;118:135-44. 10.1016/j.exer.2013.10.023 - DOI - PubMed
    1. Holekamp N, Wykoff CC, Schmitz-Valckenberg S, et al. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials. Ophthalmology 2020;127:769-83. 10.1016/j.ophtha.2019.12.009 - DOI - PubMed
    1. Tee JJL, Yang Y, Kalitzeos A, et al. Natural History Study of Retinal Structure, Progression, and Symmetry Using Ellipzoid Zone Metrics in RPGR-Associated Retinopathy. Am J Ophthalmol 2019;198:111-23. 10.1016/j.ajo.2018.10.003 - DOI - PMC - PubMed